Digital Health Technologies in Pediatric Trials
- 27 March 2022
- journal article
- research article
- Published by Springer Nature in Therapeutic Innovation & Regulatory Science
- Vol. 56 (6) , 929-933
Abstract
Background Advances in the miniaturization of sensors and other technologies provide opportunities to collect physiological and/or functional data directly from patients participating in clinical trials. The use of such technologies in children is particularly promising. Objective, quantifiable measurements made by these technologies, often on a continuous or frequent basis, may provide more robust data than the episodic reports from caregivers that are used in traditional pediatric trials. Methods We reviewed the pros and cons of these technologies for use in a variety of pediatric diseases, including seizure and neuromuscular disorders, cardiorespiratory diseases, and metabolic disorders. Results Correlation between sensor measurements and patient observations or traditional clinical measurements varied depending on the disease being evaluated. There was a notable dearth of reports on the use of digital health technology in pediatric patients. Given the range of sensors and measurements that can be made by DHTs, selection of the design, metrics and types of sensors best suited to disease evaluation presents challenges for adoption of these technologies in clinical trials. Conclusion Traditional measurements of drug effects are often deficient, particularly in the evaluation of infants and young children. The opportunity to make objective, frequent measurements may increase our power to detect and quantify responses to therapy in these populations. Further research and evaluation are needed to realize the full scientific potential of remote monitoring in pediatric clinical trials.Keywords
This publication has 31 references indexed in Scilit:
- Visual social attention in autism spectrum disorder: Insights from eye tracking studiesNeuroscience & Biobehavioral Reviews, 2014
- Cerebral palsyThe Lancet, 2014
- The 6‐minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter studyMuscle & Nerve, 2013
- A Review of Spasticity Treatments: Pharmacological and Interventional ApproachesCritical Reviews in Physical and Rehabilitation Medicine, 2013
- Wrist Actigraphy Predicts Outcome in Patients with Pulmonary HypertensionRespiration, 2012
- Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)Cardiovascular Diabetology, 2012
- Measuring activity levels of young people: the validity of pedometersBritish Medical Bulletin, 2010
- Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorderDevelopment and Psychopathology, 2008
- The application of eye‐tracking technology in the study of autismThe Journal of Physiology, 2007
- Methodologic Issues in Pediatric Outcomes ResearchAcademic Pediatrics, 2001